Am I At Risk Of Liver Cancer If I Am A Hepatitis C Carrier?

If you are a hepatitis C carrier, you may be wondering if you are also at risk of liver cancer, also commonly known as hepatocellular carcinoma. While the risk of developing liver cancer is higher for those with hepatitis C, not everyone develops liver cancer. There are other risk factors that can increase your chances of hepatocellular carcinoma such as age, lifestyle choices, and genetics. This is why it is important to talk to your doctor if you are a hepatitis C carrier about what steps you can take to reduce your chances of developing this deadly disease. 

Can Hepatitis B lead to Liver Cancer?

For people with chronic hepatitis B, the fear of developing liver cancer is always looming in the back of their minds. And rightfully so—liver cancer is one of the few cancers that is on the rise and chronic hep B is one of the main risk factors. So, can untreated hepatitis B lead to liver cancer? Let’s take a look at the science.

New and Recent Approved Systemic Treatments for Hepatocellular Carcinoma (HCC) Liver Cancer

New & recent approved systemic treatments for Hepatocellular Carcinoma (HCC)  Liver Cancer

Hepatocellular carcinoma (HCC) or primary liver cancer often presents in the advanced stage. It is an aggressive tumour that often occurs in the setting of chronic liver disease and cirrhosis of the liver. It is often discovered late, and the survival following diagnosis is often poor.  Although the mainstay of treatment is surgical operation, many patients are not suitable because of extensive tumour or poor liver function. Systemic therapy is the main treatment for these cases. In Asia, liver cancer is listed as one of the most common malignancies, in view of endemic hepatitis B and C. Advances and understanding of the disease, have led to the recent development of new systemic therapeutic options. At OncoCare Cancer Centre, Singapore, we often see patients with advanced HCC for discussion of treatment. Currently only targeted therapy and immunotherapy are the only approved modalities for systemic therapy. Chemotherapy has not been shown to prolong survival of patients with advanced HCC. Some of these therapies used at OncoCare and how they work, are discussed here.